Welbe : Results of Operations for the Second Quarter of the Fiscal Year Ending March 31, 2022

Results of Operations

for the Second Quarter of

the Fiscal Year Ending March 2022

(2Q FY3/22)

Welbe, Inc.

Securities Code : 6556

Section

01		Consolidated financial results for the second quarter
	of the fiscal year ending March 2022

02		Growth strategies

03		Full-year consolidated earnings forecast for the fiscal
	year ending March 2022

04		Sustainability of the Welbe Group

05		Reference materials

©2021 Welbe, Inc.

2

01

Consolidated financial results

for the second quarter of the fiscal year ending March 2022

Summary of financial results

Both sales and profit increased due to the consolidation of Welbe Healthcare Inc., which engages in the healthcare business, in addition to steady performance of the disability welfare business. High profitability was also maintained.

					(Million yen)
		FY3/21		FY3/22
		2Q		2Q	YoY change
	Results	Ratio to net	Results	Ratio to net
	sales	sales
Net sales	4,028	-	4,688	-	+660
（+16.4%）
Operating profit	1,110	27.6%	1,202	25.6%	+92
（+8.3%）
Ordinary profit	1,118	27.8%	1,245	26.6%	+127
（+11.4%）
Profit attributable to	728	18.1%	866	18.5%	+137
owners of parent	（+18.9%）

©2021 Welbe, Inc.

4

Progress against earnings forecast

Results for the first six months exceeded the forecast. Progress was also made smoothly against the full-year forecast.

								(Million yen)
	FY3/22	FY3/22		FY3/22
		2Q		2Q	Achieve-	Full year	Progress
					ment rate
	Results	Ratio to	Forecast	Ratio to		Forecast	Ratio to
	net sales	net sales		net sales
Net sales	4,688	-	4,485	-	104.5%	9,551	-	49.1%
Operating profit	1,202	25.6	1,126	25.1%	106.7%	2,658	27.8%	45.2%
	%
Ordinary profit	1,245	26.6	1,127	25.1%	110.4%	2,659	27.8%	46.8%
	%
Profit attributable to	866	18.5%	770	17.2%	112.5%	1,910	20.0%	45.4%
owners of parent

©2021 Welbe, Inc.

5